Survey of Optical Values of the Breast Using Radiation-Free Pressure-Free Optical Scanning
NCT ID: NCT00671385
Last Updated: 2011-02-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
2000 participants
OBSERVATIONAL
2008-04-30
2011-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Combined Digital X-ray and Ultrasound Technique for Improved Detection and Characterization of Breast Lesions
NCT00721435
Computed Optical Margin Assessment for Breast Cancer Surgery, Phase I (Part B)
NCT02313116
Breast Study to Learn More About the Application of Optical Transillumination Measurements to Assess Breast Cancer Risk and to Potentially Detect the Presence of Breast Cancer.
NCT00188721
Breast Cancer Risk Assessment Using Optical Breast Spectroscopy (OBS)
NCT00500383
Breast Density and the Role of Preoperative Mammography, Ultrasound, Elastography and MRI
NCT00695968
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Women 21-50 years old
Women without a diagnosis of cancer or a history of cancer.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* You must be 21 to 50 years old
* You must not have or have had breast cancer.
* You must not have or have had breast implants or breast surgery
* You must not have had a breast biopsy or injury, or a breast infection, in 90 days.
Exclusion Criteria
* Lack of informed consent
21 Years
50 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stanford University
OTHER
University of California
OTHER
Palo Alto Medical Foundation
OTHER
Spectros Corporation
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Spectros Corporation
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David A Benaron, MD
Role: STUDY_DIRECTOR
Spectros Corporation
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Spectros Corporation
Portola Valley, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CA126441
Identifier Type: -
Identifier Source: secondary_id
CA083597
Identifier Type: -
Identifier Source: secondary_id
BCA-003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.